ArticleEuropean journal of neurology2026
How Much Difference Does Depression Make to the Outcome of Neuropsychological Assessments of Patients With Epilepsy?
Article in European journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- How Much Difference Does Depression Make to the Outcome of Neuropsychological Assessments of Patients With Epilepsy?European journal of neurology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCognitive impairment and depression are common comorbidities in people with epilepsy (PWE). This study investigated the extent to which the severity of depression affects specific cognitive domains and quality of life (QOL) in PWE.
methodsIn 732 PWE (age 18-82 years), Beck Depression Inventory (BDI) scores were correlated with performance in several cognitive domains (attention/executive functions, motor function, memory, language, visuo-construction) and with QOL (using QOLIE-10), individually and as superordinate compounds reflecting the range and intensity of general impairment.
resultsForty-five percent of patients had mild-to-severe depression. Cognitive domains were impaired in 43%-62% of patients. Depression correlated strongly with poorer QOL (r = 0.65). In contrast, its correlations with cognition were significantly weaker (r = 0.07-0.17), explaining less than 3% of the variance across all domains. The strongest correlation was with attention/executive functions. The overall impact of depression on the range and severity of cognitive impairments was mediated by its effect on these executive functions. The minimum BDI score difference required for a clinically significant cognitive difference (> 1 SD) was domain-specific, ranging from 6 points for attention to 13 points for language. A 16-point difference was needed for a significant change in QOL.
conclusionIn PWE, depression has a severe primary impact on quality of life. Its direct effect on cognition, however, is minor. When a cognitive effect is present, it suggests hypofrontality impacting attention, executive functions, and motor skills, predominantly in the most severely depressed patients (BDI > 29). The influence of depression on global cognitive impairment is mediated through this executive dysfunction.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.